TheraPAP vs APAP for Obstructive Sleep Apnea

This trial tests a new sleep device called TheraPAP, designed to treat obstructive sleep apnea (OSA), a condition where breathing stops and starts during sleep. Researchers aim to determine if TheraPAP is more comfortable and improves usage compared to the standard APAP device, a type of positive airway pressure device. Participants will use each device for four weeks at home, and researchers will collect data on their breathing and sleep quality. Suitable candidates have OSA with moderate to severe symptoms but no other sleep disorders or serious illnesses. As an unphased trial, this study allows participants to contribute to innovative research that could enhance comfort and effectiveness in sleep apnea treatment.

Yes, if you are taking medications that affect sleep, sleepiness, or alertness, you will need to stop them to participate in this trial.

Research has shown that TheraPAP, a new device tested for obstructive sleep apnea (OSA), has promising safety results from earlier studies. The device meets key safety standards for electricity and isolation, ensuring safe use. Studies also indicate that TheraPAP remains comfortable without sacrificing effectiveness in treating OSA. This comfort is crucial, as it encourages adherence to therapy. Although TheraPAP is still under testing, these findings suggest it is well-tolerated by users.¹²³⁴⁵

Unlike the standard of care for obstructive sleep apnea, which typically involves automatic positive airway pressure (APAP) devices, TheraPAP offers a new approach under evaluation. Researchers are excited about TheraPAP because it might provide enhanced comfort and efficacy by optimizing pressure settings tailored to individual needs, potentially reducing air leaks and improving adherence. This innovation could lead to better sleep quality and outcomes for patients who struggle with traditional APAP devices.

This trial will compare TheraPAP with APAP for treating obstructive sleep apnea (OSA). Research has shown that TheraPAP, a new device for OSA, can increase patient comfort while maintaining effectiveness. In earlier studies, adding a special component to the CPAP machine made breathing easier, enhancing patient comfort without compromising treatment effectiveness. Another study found that TheraPAP can reduce sleepiness, improve quality of life, and enhance breathing over time. Users of similar devices have reported feeling less sleepy during the day and experiencing a better quality of life. These findings suggest that TheraPAP could be a promising option for managing OSA.²⁶⁷⁸⁹